Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein (Q39517095)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 28, 1978

Language	Label	Description	Also known as
English	Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein	scientific article published on December 28, 1978

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein (English)

reason for preferred rank

most precise value

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

1 reference

based on heuristic

inferred from title

author name string

Borgá O

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Odar-Cederlöf I

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

K. M. Piafsky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

O. Borgá

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

I. Odar-Cederlöf

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

C. Johansson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

F. Sjöqvist

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82206

8 November 2022

language of work or name

0 references

publication date

1 December 1978

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

28 December 1978

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=82206

8 November 2022

full work available at URL

http://www.nejm.org/doi/pdf/10.1056/NEJM197812282992604

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

The New England Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

299

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1435-1439

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Methadone binding to human plasma albumin

1

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Methadone binding to human plasma proteins

2

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Acta pharmaceutica Suecica

3

11

325

author name string

Appelgren

publication date

1974

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity.

4

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Increased plasma binding of quinidine after surgery: a preliminary report

7

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation

8

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Steroid-Protein Interactions. XIV. Interaction between Human α1-Acid Glycoprotein and Progesterone*

12

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Steroid-protein interactions. XIX. Complex formation between alpha 1-acid glycoprotein and steroid hormones

13

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Interindividual Differences in the Protein Binding of Sulfonamides: The Effect of Disease and Drugs 1,2

14

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

15

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors

16

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

The binding of drugs to plasma proteins from patients with poor renal function

17

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone

19

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

The role of plasma protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine.

20

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake

21

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Commentary: a physiological approach to hepatic drug clearance

22

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

24

1 reference

10.1056/NEJM197812282992604

https://api.crossref.org/works/10.1056/NEJM197812282992604

8 November 2022

Identifiers

10.1056/NEJM197812282992604

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39517095&oldid=1767129927"